NRX Pharmaceuticals, Inc. (NASDAQ:NRXP)
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Loses money on what it sells.
- Revenue
- $3.4M
- Net income
- -$23.5M
- Net margin
- -691.8%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $1.2M
- Cash
- $26.7M
Owes more within a year than it holds to pay it.
- Current assets
- $29.2M
- Current liabilities
- $33.9M
- Current ratio
- 0.86
Consumes cash and must keep raising it.
- Operating cash flow
- -$19.8M
- Free cash flow
- -$20.7M
- FCF margin
- -609.0%
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 37.6M
- Share growth (1y)
- 109.9%
- Cash runway
- 16 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
NRXP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $1.10 M | $1.07 M | $983.00 K | $242.00 K | $0.00 | $0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | $843.00 K | $796.00 K | $508.00 K | $138.00 K | $0.00 | $0.00 |
| Gross Profit | $258.00 K | $272.00 K | $475.00 K | $104.00 K | $0.00 | $0.00 |
| SG&A Expense | $4.75 M | $3.71 M | $4.51 M | $2.79 M | $2.74 M | $2.94 M |
| R&D Expense | $2.12 M | $1.31 M | $558.00 K | $1.43 M | $987.00 K | $804.00 K |
| Operating Expenses | $6.76 M | $5.02 M | $5.07 M | $4.22 M | $3.73 M | $3.85 M |
| Operating Income | -$6.50 M | -$4.75 M | -$4.59 M | -$4.12 M | -$3.73 M | -$3.85 M |
| Pretax Income | -$16.52 M | -$1.43 M | $360.00 K | -$5.89 M | -$17.58 M | -$5.51 M |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$16.52 M | -$1.43 M | $360.00 K | -$5.89 M | -$17.58 M | -$5.51 M |
| EPS (Basic) | -$0.44 | -$0.04 | $0.01 | -$0.27 | -$0.98 | -$0.34 |
| EPS (Diluted) | -$0.44 | -$0.04 | $0.01 | -$0.27 | -$0.98 | -$0.34 |
| Shares Outstanding | 37.65 M | 32.33 M | 31.73 M | 22.23 M | 17.93 M | 16.41 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.